Mirko Signorelli, Burcu Ayoglu, Camilla Johansson, Hanns Lochmüller, Volker Straub, Francesco Muntoni, . . . Pietro Spitali. (2020). Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. Wiley.
Chicago Style (17th ed.) CitationMirko Signorelli, et al. Longitudinal Serum Biomarker Screening Identifies Malate Dehydrogenase 2 as Candidate Prognostic Biomarker for Duchenne Muscular Dystrophy. Wiley, 2020.
MLA (9th ed.) CitationMirko Signorelli, et al. Longitudinal Serum Biomarker Screening Identifies Malate Dehydrogenase 2 as Candidate Prognostic Biomarker for Duchenne Muscular Dystrophy. Wiley, 2020.
Warning: These citations may not always be 100% accurate.